ARCHIVES

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

Omnibus bill recissions would cut $28 million from NCI FY04 budget.

January 9, 2004

ASCO Seeks “Nothing Less Than A Smoke-Free World”

June 6, 2003

Pryor Calls For Price Regulation Of Drugs In Health Reform

February 12, 1993

Celgene Begins Two Studies With Hoffmann-La Roche.

June 29, 2001

IOM Report Links Agent Orange, CLL

January 24, 2003

DCCR Plans Three Multiple Contracts In Pain Control

February 17, 1978